Fortification of human milk for feeding preterm infants: What is the ideal strategy?

Fernando Moya1

  • 1Pediatrix Medical Group of Austin, Clinical Professor of Pediatrics, Texas A & M College of Medicine, 900 E. 30th Street, Suite 211, Austin, TX, 78705, USA.

Insights

Optimizing preterm infant growth in the Neonatal Intensive Care Unit (NICU) is crucial for development. Human milk fortification strategies are debated but essential for providing adequate nutrition and improving outcomes for vulnerable infants.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Gastroenterology
  • Infant Development

Background:

  • Optimal growth in preterm infants during NICU stays is linked to better neurodevelopment and reduced morbidity.
  • Human milk (HM) feeding is standard for preterm infants, reducing complications like necrotizing enterocolitis.
  • However, HM alone often lacks sufficient protein and nutrients for adequate infant growth.

Purpose of the Study:

  • To review and discuss various human milk fortification strategies for preterm infants.
  • To explore the benefits and optimal timing of different human milk fortifiers.
  • To address the ongoing debate regarding the best fortification approaches for growth and neurodevelopment.

Main Methods:

  • Review of current literature and expert opinions on human milk fortification.
  • Discussion of different types of human milk fortifiers (human or bovine origin).
  • Analysis of fortification timing and its impact on preterm infant outcomes.

Main Results:

  • Human milk fortifiers supplement protein, minerals (sodium, calcium, phosphorus), vitamins, and micronutrients.
  • Different fortification strategies may offer varied benefits for preterm infant growth.
  • The optimal fortification approach remains an area of active research and clinical discussion.

Conclusions:

  • Human milk fortification is necessary to meet the nutritional demands of preterm infants.
  • Evidence-based strategies are needed to guide the selection and timing of fortifiers.
  • Further research is essential to optimize fortification for improved growth and neurodevelopmental outcomes.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
73